These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10771384)

  • 1. Evaluating leucodepletion systems suitable for routine use.
    Rowe G
    Transfus Sci; 2000; 22(1-2):61-2. PubMed ID: 10771384
    [No Abstract]   [Full Text] [Related]  

  • 2. Leucodepletion and regulatory aspects in Germany.
    Heiden M; Keller-Stanislawski B
    Transfus Sci; 2000; 22(1-2):69-70. PubMed ID: 10771387
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective or universal leucodepletion: the Italian experience.
    Accorsi P; Iacone A
    Transfus Sci; 2000; 22(1-2):65-7. PubMed ID: 10771386
    [No Abstract]   [Full Text] [Related]  

  • 4. Systematic RBC leucodepletion in France: where are we after six months?
    Masse M
    Transfus Sci; 2000; 22(1-2):57-9. PubMed ID: 10771383
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors influencing the outcome of leucodepletion system.
    Seghatchian J; Krailadsiri P
    Transfus Sci; 2000; 22(1-2):135-7. PubMed ID: 10771402
    [No Abstract]   [Full Text] [Related]  

  • 6. Double plateletpheresis (DPA) and tailored RBC collection with the Excel-Pro: preliminary results.
    Valbonesi M; Bruni R; Bo A; De Luigi MC; Stura P; Carlier P; Sanfilippo B
    Transfus Apher Sci; 2001 Feb; 24(1):71-3. PubMed ID: 11515613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National evaluation of IMAGN 2000 for quality monitoring of leucodepleted red cell and platelet concentrates: comparison with flow and Nageotte.
    Seghatchian J; Krailadsiri P; Chandegra B; Beard M; Beckman N; Bissett L; Morris B; Booker W
    Transfus Sci; 2000; 22(1-2):77-9. PubMed ID: 10771390
    [No Abstract]   [Full Text] [Related]  

  • 8. Leucodepletion monitoring by flow cytometry (Becton-Dickinson): from universal to statistical process monitoring.
    Barclay R; McColl K; Walker B
    Transfus Sci; 2000; 22(1-2):63-4. PubMed ID: 10771385
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimization of parameters for maximization of plateletpheresis and lymphocytapheresis yields on the Haemonetics Model V50.
    AuBuchon JP; Carter CS; Adde MA; Meyer DR; Klein HG
    J Clin Apher; 1986; 3(2):103-8. PubMed ID: 3700354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines as quality indicators of leucoreduced red cell concentrates.
    Seghatchian J; Krailadsiri P; Dilger P; Thorpe R; Wadhwa M
    Transfus Apher Sci; 2002 Feb; 26(1):43-6. PubMed ID: 11931377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of random donor leukocyte-poor platelets by cytapheresis.
    Olthuis HP; Stienstra S; Puylaert CE; Verhagen CM; Bär BM
    Transfus Sci; 1993 Apr; 14(2):195-7. PubMed ID: 10148612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of leukodepleted blood products.
    Heaton A
    Transfus Sci; 1995 Jun; 16(2):189-92. PubMed ID: 10155739
    [No Abstract]   [Full Text] [Related]  

  • 13. The UK strategy for monitoring universal leucodepletion.
    Beckman N; Seghatchian J
    Transfus Sci; 1999 Oct; 21(2):147-51. PubMed ID: 10747523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Performance of Pall filters (RC 100 and PL 100) for the removal of leukocytes from red-cell concentrates and platelets].
    Hurel C; Sabolic V; Habibi B
    Rev Fr Transfus Hemobiol; 1989 Sep; 32(4):307-22. PubMed ID: 2818773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A national quality assessment scheme for counting residual leucocytes in unfixed leucodepleted products: the effect of standardisation and 48 hour storage.
    Krailadsiri P; Seghatchian J; Rigsby P; Bukasa A; Bashir S
    Transfus Apher Sci; 2002 Feb; 26(1):73-81. PubMed ID: 11931380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the leuko-reductive efficacy of single-donor erythropheresis procedures].
    Domingo JM; Rabasa P; Chueca P; Medarde A
    Sangre (Barc); 1999 Jun; 44(3):238-40. PubMed ID: 10481589
    [No Abstract]   [Full Text] [Related]  

  • 17. Variable leukocyte composition of red blood cell concentrates prepared in top-bottom systems: possible implications for pre-transplant blood transfusion.
    Weinreich SS; Remmerswaal EB; Laport R; van Rhenen DJ; Rombout-Sastrienkova E; Smit Sibinga CT; Vrielink H; Boog CJ
    Vox Sang; 2000; 79(2):83-6. PubMed ID: 11054045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Production of leukocyte- and thrombocyte-poor erythrocyte preparations].
    Kretschmer V; Köppen-Castrop A; Söhngen D; Lammers M; Egbring R; Prinz H
    Beitr Infusionther Klin Ernahr; 1987; 18():151-4. PubMed ID: 3439961
    [No Abstract]   [Full Text] [Related]  

  • 19. A multicentre evaluation of a new filtration protocol for leucocyte depletion of high-haematocrit red blood cells collected by an automated blood collection system.
    Soli M; Blanco L; Riggert J; Martínez-Clavel A; Lucas C; Lunghi M; Belloni M; Wolf C; van Waeg G; Antoon M
    Vox Sang; 2001; 81(2):108-12. PubMed ID: 11555470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective comparison of high-dose plateletpheresis with the latest apheresis systems on the same donors.
    Picker SM; Radojska SM; Gathof BS
    Transfusion; 2006 Sep; 46(9):1601-8. PubMed ID: 16965590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.